Anti-Inflammatory and Antinociceptive Action of an Orally Available Nociceptin Receptor Agonist SCH 221510 in a Mouse Model of Inflammatory Bowel Diseases-Reference-Cited by-同舟云学术

Anti-Inflammatory and Antinociceptive Action of an Orally Available Nociceptin Receptor Agonist SCH 221510 in a Mouse Model of Inflammatory Bowel Diseases

Published:2013-12-17 Issue:3 Volume:348 Page:401-409
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Sobczak Marta,Mokrowiecka Anna,Cygankiewicz Adam I.,Zakrzewski Piotr K.,Sałaga Maciej,Storr Martin,Kordek Radzisław,Małecka-Panas Ewa,Krajewska Wanda M.,Fichna Jakub

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference31 articles.

1. Peripheral anti-nociceptive effect of nociceptin/orphanin FQ in inflammation and stress-induced colonic hyperalgesia in rats

2. CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity

3. Gastrointestinal effects of intracerebroventricularly injected nociceptin/orphaninFQ in rats

4. Nociceptin/orphanin FQ receptor ligands

5. Cognitive functioning and depressive symptoms in adolescents with inflammatory bowel disease

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nociceptin Receptor-Related Agonists as Safe and Non-addictive Analgesics;Drugs;2023-05-20

2. Abdominal Pain in Inflammatory Bowel Diseases: A Clinical Challenge;Journal of Clinical Medicine;2022-07-22

3. Interactions between the Nociceptin and Toll-like Receptor Systems;Cells;2022-03-23

4. Spotlight on Nociceptin/Orphanin FQ Receptor in the Treatment of Pain;Molecules;2022-01-18

5. Colonic inflammation induces changes in glucose levels through modulation of incretin system;Pharmacological Reports;2021-09-17